11
Progressive Multifocal Intraocular Lens G. Rubiolini M.D. Italy www.grvision.com Disclosure of finanacial interest Author's research is partially funded by Imperial Medical Technologies (Cartersville GA, USA) producing, developing and supplying the product presented

Progressive Multifocal Intraocular Lens G. Rubiolini M.D. Italy grvision

  • Upload
    matteo

  • View
    43

  • Download
    0

Embed Size (px)

DESCRIPTION

Progressive Multifocal Intraocular Lens G. Rubiolini M.D. Italy www.grvision.com. Disclosure of finanacial interest Author's research is partially funded by Imperial Medical Technologies (Cartersville GA, USA) producing, developing and supplying the product presented . PURPOSE . - PowerPoint PPT Presentation

Citation preview

Page 1: Progressive Multifocal Intraocular Lens  G.  Rubiolini  M.D. Italy grvision

Progressive Multifocal Intraocular Lens

G. Rubiolini M.D.Italywww.grvision.com

Disclosure of finanacial interestAuthor's research is partially funded by Imperial

Medical Technologies (Cartersville GA, USA) producing, developing and supplying the product presented

Page 2: Progressive Multifocal Intraocular Lens  G.  Rubiolini  M.D. Italy grvision

PURPOSE This is the first clinical trial to evalutate safety long term visual outcomes in a selected group of patient with cataract of this "premium" IOL, available in two versions: modified “C” style Micro-Incision Plate style “Progressive Multifocal” lens that uses a new optical geometry.

Page 3: Progressive Multifocal Intraocular Lens  G.  Rubiolini  M.D. Italy grvision

Materials and methods 35 patients (20 F ,15M. Mid age 56) had

bilateral Progressive Multi-Focal Intraocular Lenses implants with a non-linear reading add from +3.0 Diopter to +4.5(progressive)during cataract surgery ( PRESBIOPTICx by IMT, Cartersville GA USA). Exclusion criteria included but was not limited to astigmatism >1D, diabetic retinopathy, maculopathy and previous ocular surgery.

Page 4: Progressive Multifocal Intraocular Lens  G.  Rubiolini  M.D. Italy grvision

Materials and methods Biometry:

IOLMaster Zeiss Target refraction:

emmetropia

Facochop procedure (Stellaris B&L)

IOL implantation in the capsular bag.

Injector : Medicel VISCOJECTTM 2.2 mm

Page 5: Progressive Multifocal Intraocular Lens  G.  Rubiolini  M.D. Italy grvision

Materials and MethodsEIOLs characteristics Optic 6 mm Length 11 mm

(plate) 12 mm (c-loop)

AC Depth 5.3 mm A constant 118.4 Sugested IOL

formula : Holladay Biometry: IOLMaster Zeiss Target refraction: emmetropia

PRESBIOPTICxMicro Incision

PRESBIOPTICx Modified “C”

Page 6: Progressive Multifocal Intraocular Lens  G.  Rubiolini  M.D. Italy grvision

Implanting PRESBIOPTICxTM

18.0D + 4.00 4.10D - 4.30D 19.0D + 3.80 3.90D – 4.10D 20.0D + 3.60 3.70D – 3.90D 21.0D + 3.40 3.50D – 3.70D 22.0D + 3.20 3.30D – 3.50D 23.0D + 3.00 3.10D – 3.30D

• First Lens Implanted - If emmetropia & near vision achieved then the second lens Implanted is identical. • First Lens Implanted - If near vision is not achieved then second lens can correct the problem.

DIOPTER OPTICAL ADD 2nd Lens Availability

Page 7: Progressive Multifocal Intraocular Lens  G.  Rubiolini  M.D. Italy grvision

IOLs surfaces comparisons

PRESBIOPTICxHP60CMImperial MedicalTechnologies Cartersville, GAUSA

Standard MultifocalIOL

Page 8: Progressive Multifocal Intraocular Lens  G.  Rubiolini  M.D. Italy grvision

18,5D 19D 20D 20,5D 21 D 21,5D 22D 23D 23,5D 24D 25D

3

2 2

4

6

4 4 4

2

1

3

IOLs Diopters Implanted

Page 9: Progressive Multifocal Intraocular Lens  G.  Rubiolini  M.D. Italy grvision

RESULTS: 12 to 24 months follow up

Total freedom from glasses was achieved in 28 patients (>80%) with two similar near addition implants (Standard PRESBIOPTICx).

5 patients received an extra 0.40D addition for the second eye(Customized PRESBIOPTICx). Considering this group too, 33 patients (95%) achieved J2 best uncorrected near visual acuity with bilateral vision.

100%of the patients achieved 20/25 or better uncorrected visual acuity for distance.

2 Patients complained some temporary (2-3 months) night vision problems such as glare, halos and sparkles (5,7%).

Page 10: Progressive Multifocal Intraocular Lens  G.  Rubiolini  M.D. Italy grvision

CONCLUSION This revolutionary progressive addition

system for multifocal IOLs provides a excellent visual acuity for distance and near and it can be eventually customized.

Full range vision can be achieved in 95% of the cases .

We found a significant reduction of temporary side effects of multifocal IOLs such as glare, halos and sparkles (5,7%).

Page 11: Progressive Multifocal Intraocular Lens  G.  Rubiolini  M.D. Italy grvision

Thank You